CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy
Public ClinicalTrials.gov record NCT00257205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open Label, Randomized, Comparative Study Of CP-675,206 And Either Dacarbazine Or Temozolomide In Patients With Advanced Melanoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3, multi-national, open-label, 2-arm randomized study in patients with surgically incurable metastatic melanoma who have received no prior chemotherapy, or biochemotherapy for the treatment of metastatic disease. The primary objective of this trial is to compare overall survival for patients with advanced melanoma who are randomized to receive CP-675,206 with that of patients who are randomized to receive either dacarbazine or temozolomide (investigator choice)
Study identification
- NCT ID
- NCT00257205
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 655 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2006
- Primary completion
- Jul 31, 2010
- Completion
- Jul 31, 2010
- Last update posted
- Jul 1, 2012
2006 – 2010
United States locations
- U.S. sites
- 55
- U.S. states
- 21
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35805 | — |
| Research Site | Mobile | Alabama | 36607 | — |
| Research Site | Scottsdale | Arizona | 85260 | — |
| Research Site | Little Rock | Arkansas | 72205 | — |
| Research Site | Bakersfield | California | 93309 | — |
| Research Site | Corona | California | 92879 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Glendora | California | 91741 | — |
| Research Site | Huntington Beach | California | 92648 | — |
| Research Site | Long Beach | California | 90813 | — |
| Research Site | Los Alamitos | California | 90720 | — |
| Research Site | Los Angeles | California | 90095-6970 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Oxnard | California | 93030 | — |
| Research Site | Pasadena | California | 91105 | — |
| Research Site | Pomona | California | 91767 | — |
| Research Site | Rancho Cucamonga | California | 91730 | — |
| Research Site | Santa Barbara | California | 93105 | — |
| Research Site | Santa Maria | California | 93454 | — |
| Research Site | West Covina | California | 91790 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Stamford | Connecticut | 06902-3628 | — |
| Research Site | Boynton Beach | Florida | 33426 | — |
| Research Site | Lake Worth | Florida | 33461-4710 | — |
| Research Site | Zion | Illinois | 60099 | — |
| Research Site | Beech Grove | Indiana | 46107 | — |
| Research Site | Indianapolis | Indiana | 46237 | — |
| Research Site | Indianapolis | Indiana | 46260 | — |
| Research Site | Baltimore | Maryland | 21237-3998 | — |
| Research Site | City of Saint Peters | Missouri | 63376 | — |
| Research Site | Creve Coeur | Missouri | 63141 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Omaha | Nebraska | 68114 | — |
| Research Site | Henderson | Nevada | 89015 | — |
| Research Site | Henderson | Nevada | 89052 | — |
| Research Site | Las Vegas | Nevada | 89109 | — |
| Research Site | Las Vegas | Nevada | 89128 | — |
| Research Site | Las Vegas | Nevada | 89135 | — |
| Research Site | Las Vegas | Nevada | 89148 | — |
| Research Site | Morristown | New Jersey | 07962 | — |
| Research Site | Albany | New York | 12206 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | Chapel Hill | North Carolina | 27599-7600 | — |
| Research Site | Charlotte | North Carolina | 28203 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Canton | Ohio | 44718 | — |
| Research Site | Columbus | Ohio | 43210 | — |
| Research Site | Dover | Ohio | 44718 | — |
| Research Site | Bethlehem | Pennsylvania | 18015 | — |
| Research Site | Pittsburgh | Pennsylvania | 15232 | — |
| Research Site | Dallas | Texas | 75246 | — |
| Research Site | Salt Lake City | Utah | 84112 | — |
| Research Site | Federal Way | Washington | 98003 | — |
| Research Site | Lakewood | Washington | 98499 | — |
| Research Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.
Recently updated Melanoma trials
Other public records listing Melanoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT07339176: Intratumoral N17350 in Advanced Solid Tumors Recruiting
- NCT07720726: Impact of Dysport on PMFF Donor Scar Not yet recruiting
- NCT06529822: Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease Recruiting
- NCT07704918: Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma Not yet recruiting
- NCT04407247: Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Active, not recruiting
- NCT06580002: Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00257205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2012 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00257205 live on ClinicalTrials.gov.